It is possible to live for 20 years or more with non-Hodgkin's lymphoma (NHL), depending on the type and stage of the disease. NHL is a type of cancer that affects the lymphatic system, which is a network of vessels and organs that help the body fight infection. NHL is usually divided into two categories: slow-growing (indolent) and aggressive (fast-growing) types.
For those with indolent NHL, survival rates are high and patients can expect to live for 10-20 years or more. Treatment for indolent NHL often involves watchful waiting, observation, and occasional changes in therapy. The goal is to keep the disease under control with minimal side effects.
For those with aggressive NHL, survival rates are lower and tend to vary depending on factors such as age and the type of NHL. Treatment for aggressive NHL typically involves chemotherapy and radiation, and sometimes a combination of both. Response rates to these treatments can vary from person to person, so it is difficult to predict how long a person may live with aggressive NHL.
Overall, it is possible to live for 20 years or more with NHL, depending on the type and stage of the disease. Those with indolent NHL may have a better prognosis and can expect to live for 10-20 years or more. For those with aggressive NHL, survival rates may vary depending on individual factors. It is important to talk to your doctor about the best treatment options for you and to discuss your prognosis.